Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

ENZY

ENZYMOTEC LTD. (ENZY)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENZY
DataOraFonteTitoloSimboloCompagnia
19/02/201908:00GlobeNewswireEnzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in GermanyNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
30/01/201908:30GlobeNewswireEnzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZymeNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
25/01/201908:30GlobeNewswireEnzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claimsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/12/201814:30GlobeNewswireEnzymatica AB: Appeal on Enzymatica's cold spray in Germany overruledNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
02/12/201818:00GlobeNewswireEnzymatica AB: Enzymatica raises SEK 98.7 million in completed share issueNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
12/11/201813:00GlobeNewswireEnzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders publishedNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
05/11/201811:15GlobeNewswireEnzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
02/11/201809:00GlobeNewswireEnzymatica AB: Enzymatica's rights issue is secured up to 100 percentNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
31/10/201808:30GlobeNewswireEnzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in GermanyNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
18/10/201808:30GlobeNewswireEnzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
18/10/201808:00GlobeNewswireEnzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 millionNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
18/10/201807:30GlobeNewswireEnzymatica AB: Enzymatica signs agreement for the Japanese marketNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
01/10/201808:30GlobeNewswireEnzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold sympto...NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
29/08/201808:30GlobeNewswireEnzymatica AB: Appeal of court ruling on Enzymatica's cold spray in GermanyNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
31/07/201813:00GlobeNewswireEnzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South AfricaNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/07/201808:30GlobeNewswireEnzymatica AB: Lower sales in Q2 but 31% increase for the first half of the yearNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/07/201808:30GlobeNewswireEnzymatica AB: Court ruling put restrictions on marketing of Enzymatica's cold spray in GermanyNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
07/06/201808:30GlobeNewswireEnzymatica AB: Enzymatica secures funding for operationsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
22/05/201808:30GlobeNewswireEnzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and CyprusNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
26/04/201815:30GlobeNewswireEnzymatica AB: Bulletin from annual general meeting 2018 in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
26/04/201808:30GlobeNewswireEnzymatica AB: Continued growth during the first quarterNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
11/04/201808:45GlobeNewswireEnzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virusNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
09/04/201811:30GlobeNewswireEnzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illnessNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
28/03/201808:30GlobeNewswireEnzymatica AB: Enzymatica - publication of the annual report 2017NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
21/03/201813:00GlobeNewswireEnzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
14/02/201808:00GlobeNewswireEnzymatica AB: Strong growth and international breakthrough in 2017NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
13/02/201812:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
22/01/201814:55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
11/01/201814:35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
11/01/201814:27Edgar (US Regulatory)(25-NSE)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENZY
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network